Bangladesh Pharmaceuticals and Healthcare Report Q4 2014

Business Monitor International
September 17, 2014
110 Pages - SKU: BMI5329125
Countries covered: Bangladesh

Bangladesh Pharmaceuticals and Healthcare Report Q4 2014

BMI View: We consider Bangladesh's commitment to another round of spending on the development ofhealthcare, information technology, infrastructure, energy production, education, agriculture and foodsecurity and transportation in fiscal year 2014/2015 as a sound investment. While we are optimistic thatongoing tax reform efforts by the government will rake in more revenues to support development spending,and keep the country's budget deficit manageable at around 3.0% of GDP over the coming years, the lackof government revenues remains a major obstacle to Bangladesh's economic development and may delaymuch-needed investments in improving the population's access to healthcare.

Headline Expenditure Projections

Pharmaceuticals: BDT138.81bn (USD1.78bn) in 2013 to BDT154.74bn (USD1.99bn) in 2014; +11.5%in local currency terms and +12.1% in US dollar terms

Healthcare: BDT375.52bn (USD4.81bn) in 2013 to BDT419.78bn (USD5.41bn) in 2014; +11.8% inlocal currency terms and +12.4% in US dollar terms



More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Bangladesh Prescription Drugs reports

Pharmaceuticals and Healthcare : Bangladesh Pharmaceuticals and Healthcare Report Q3 2014 by Business Monitor International
Pharmaceuticals and Healthcare : Bangladesh Pharmaceuticals and Healthcare Report Q3 2014BMI View: It is vital that Bangladesh's government works to improve the business environment for ...
Antibiotics Market in Bangladesh to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Bangladesh. The study provides essential market ...
The Pharmaceutical Market: Bangladesh by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
The Pharmaceutical Market: Bangladesh (pdf/xls) by Espicom Healthcare Intelligence
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!